Brief: Polypeptide Group Says It Is Conducting Review Of Strategic Options
14/04/2026 06:04
April 14 (Reuters) - POLYPEPTIDE GROUP AG PPGN.S: TAKES NOTE OF MARKET RUMORS AND SPECULATION AS A MATTER OF POLICY, POLYPEPTIDE DOES NOT COMMENT ON RUMORS AND SPECULATION CONDUCTING A REVIEW OF POTENTIAL STRATEGIC OPTIONS MARKET SPECULATION AND MEDIA REPORTS ACCORDING TO WHICH POLYPEPTIDE HAS ATTRACTED TAKEOVER INTEREST FROM CERTAIN INVESTORS Source text: ID:nEQ8bmfpma Further company coverage: PPGN.S (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com ; +48 587785269;;))
Recent news on PolyPeptide AG
See all newsEurope Research Roundup: Assa Abloy, DHL, Randstad
Brief: Polypeptide Is Said To Shortlist EQT, IDG For Next Bidding Round - Bloomberg News
Brief: Polypeptide Group Says It Is Conducting Review Of Strategic Options
PolyPeptide attracts takeover interest from EQT, KKR, Bloomberg News reports
Media: PolyPeptide Is Said to Attract Takeover Interest From EQT, KKR - Bloomberg News